500
T. Pal et al.
de Menezes BRC, Rodrigues KF, da Fonseca BCS et al (2019) Recent advances in the use of carbon
nanotubes as smart biomaterials. J Mater Chem B 7:1343–1360
Ekladious I, Colson YL, Grinstaff MW (2019) Polymer–drug conjugate therapeutics: advances,
insights and prospects. Nat Rev Drug Discov 18:273–294
Larsen AK, Escargueil AE, Skladanowski A (2000) Resistance mechanisms associated with altered
intracellular distribution of anticancer agents. Pharmacol Ther 85:217–229
Mandal A (2017) Copper nanomaterials as drug delivery system against infectious agents and
cancerous cells. J Appl Life Sci Int 15:1–8
Naidu MUR, Ramana GV, Rani PU et al (2004) Chemotherapy-induced and/or radiation therapyinduced oral mucositis–complicating the treatment of cancer. Neoplasia 6:423–431
Navya PN, Daima HK (2016) Rational engineering of physicochemical properties of nanomaterials
for biomedical applications with nanotoxicological perspectives. Nano Converg 3:1
Olusanya TOB, Haj Ahmad RR, Ibegbu DM et al (2018) Liposomal drug delivery systems and
anticancer drugs. Molecules 23:907
Patel SC, Lee S, Lalwani G et al (2016) Graphene-based platforms for cancer therapeutics. Ther
Deliv 7:101–116
Pemovska T, Bigenzahn JW, Superti-Furga G (2018) Recent advances in combinatorial drug
screening and synergy scoring. Curr Opin Pharmacol 42:102–110
Rosenblum D, Joshi N, Tao W et al (2018) Progress and challenges towards targeted delivery of
cancer therapeutics. Nat Commun 9:1410
Sied M, Filli, Abdalla A et al (2019) The impact of physicochemical characteristics on therapeutic
efficacy of anticancer nanomaterials: a review. Int J Pharm Sci Drug Res 11